Zealand Pharma A/S logo

ZEAL - Zealand Pharma A/S Share Price

DKK181.2 -4.8  -2.6%

Last Trade - 16/10/19

Sector
Healthcare
Size
Mid Cap
Market Cap £749.4m
Enterprise Value £617.9m
Revenue £3.82m
Position in Universe 299th / 1487
Bullish
Bearish
Unlock ZEAL Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ZEAL Revenue Unlock ZEAL Revenue

Net Income

ZEAL Net Income Unlock ZEAL Revenue

Normalised EPS

ZEAL Normalised EPS Unlock ZEAL Revenue

PE Ratio Range

ZEAL PE Ratio Range Unlock ZEAL Revenue

Dividend Yield Range

ZEAL Dividend Yield Range Unlock ZEAL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ZEAL EPS Forecasts Unlock ZEAL Revenue
Profile Summary

Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment. Furthermore, the Company collaborates with a number of partners, such as Sanofi, Helsinn, Boehringer Ingelheim, Abbvie and Eli Lilly.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated April 1, 1997
Public Since November 1, 2010
No. of Shareholders: 16,204
No. of Employees: 172
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange - Copenhagen
Shares in Issue 35,801,238
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ZEAL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ZEAL
Upcoming Events for ZEAL
Similar to ZEAL
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.